World Health Organization. Guidelines for the treatment of Treponema pallidum (syphilis). 2016. http://www.who.int (last accessed 26 September 2016).
Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1-137.
Centers for Disease Control and Prevention. Sexually transmitted disease surveillance, 2014. November 2015. http://www.cdc.gov (last accessed 26 September 2016).
Syphilis. In: Kimberlin DW, Brady MT, eds. Red Book: 2015 report of the Committee on Infectious Diseases. 30th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2015:755-768.
US Preventive Services Task Force. Screening for syphilis infection in pregnancy: US Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2009;150:705-709.
United States Preventive Services Task Force. Syphilis infection in nonpregnant adults and adolescents: screening. July 2016. http://www.uspreventiveservicestaskforce.org/ (last accessed 26 September 2016).
Centers for Disease Control and Prevention. Recommendations for partner services programs for HIV infection, syphilis, gonorrhea, and chlamydial infection. MMWR Recomm Rep. 2008;57:1-83.
British Association for Sexual Health and HIV (BASHH). UK national guidelines on the management of syphilis. December 2015. http://www.bashh.org/ (last accessed 26 September 2016).
Stoner BP. Current controversies in the management of adult syphilis. Clin Infect Dis. 2007;44(suppl 3):S130-S146.
Parkes R, Renton A, Meheus A, et al. Review of current evidence and comparison for effective syphilis treatment in Europe. Int J STD AIDS. 2004;15:73-88.
Katz KA, Klausner JD. Azithromycin resistance in Treponema pallidum. Curr Opin Infect Dis. 2008;21:83-91.
2. World Health Organization. Guidelines for the treatment of Treponema pallidum (syphilis). 2016. http://www.who.int (last accessed 26 September 2016).
3. Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1-137.
4. Mindel A, Tovey SJ, Timmins DJ, et al. Primary and secondary syphilis, 20 years' experience. 2. Clinical features. Genitourin Med. 1989;65:1-3.
5. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance, 2014. November 2015. http://www.cdc.gov (last accessed 26 September 2016).
6. Centers for Disease Control and Prevention. National plan to eliminate syphilis from the United States. 2006. http://www.cdc.gov (last accessed 26 September 2016).
7. Renton AM, Borisenko KK, Meheus A, et al. Epidemics of syphilis in the newly independent states of the former Soviet Union. Sex Transm Infect. 1998;74:165-166.
8. Simms I, Fenton KA, Ashton M, et al. The re-emergence of syphilis in the United Kingdom: the new epidemic phases. Sex Transm Dis. 2005;32:220-226.
9. Borisenko KK, Trichonova LI, Renton AM. Syphilis and other sexually transmitted infections in the Russian Federation. Int J STD AIDS. 1999;10:665-668.
10. Salavastru C, Rusinoiu A, Parvu A, et al. Epidemiological surveillance of syphilis patients in Colentina Hospital (Bucharest, Romania). Roum Arch Microbiol Immunol. 2007;66:80-84.
11. Tucker JD, Cohen MS. China's syphilis epidemic: epidemiology, proximate determinants of spread, and control responses. Curr Opin Infect Dis. 2011;24:50-55.
12. Tucker JD, Yin YP, Wang B, et al. An expanding syphilis epidemic in China: epidemiology, behavioural risk and control strategies with a focus on low-tier female sex workers and men who have sex with men. Sex Transm Infect. 2011;87(suppl 2):ii16-18.
13. Izard J, Renken C, Hsieh CE, et al. Cryo-electron tomography elucidates the molecular architecture of Treponema pallidum, the syphilis spirochete. J Bacteriol. 2009;191:7566-7580.
15. Centers for Disease Control and Prevention. Transmission of primary and secondary syphilis by oral sex - Chicago, Illinois, 1998-2002. MMWR Morb Mortal Wkly Rep. 2004;53:966-968.
16. Edwards S, Carne C. Oral sex and transmission of non-viral STIs. Sex Transm Infect. 1998;74:95-100.
17. Clark EG, Danbolt N. The Oslo study of the natural course of untreated syphilis. Med Clin North Am. 1964;48:613-621.
18. Schroeter AL, Turner RH, Lucas JB, et al. Therapy for incubating syphilis. Effectiveness of gonorrhea treatment. JAMA. 1971;218:711-713.
19. Schober PC, Gabriel G, White P, et al. How infectious is syphilis? Br J Vener Dis. 1983;59:217-219.
20. Peterman TA, Heffelfinger JD, Swint EB, et al. The changing epidemiology of syphilis. Sex Transm Dis. 2005;32(10 suppl):S4-S10.
21. Centers for Disease Control and Prevention. Outbreak of syphilis among men who have sex with men - Southern California, 2000. MMWR Morb Mortal Wkly Rep. 2001;50:117-120.
22. Rolfs RT, Nakashima AK. Epidemiology of primary and secondary syphilis in the United States, 1981 through 1989. JAMA. 1990;264:1432-1437.
23. Rolfs RT, Goldberg M, Sharrar RG. Risk factors for syphilis: cocaine use and prostitution. Am J Public Health. 1990;80:853-857.
24. Saloojee H, Velaphi S, Goga Y, et al. The prevention and management of congenital syphilis: an overview and recommendations. Bull World Health Organ. 2004;82:424-430.
25. Holmes KK, Levine R, Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Organ. 2004;82:454-461.
26. Tobian AA, Serwadda D, Quinn TC, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med. 2009;360:1298-1309.
27. Brown DL, Frank JE. Diagnosis and management of syphilis. Am Fam Physician. 2003;68:283-290.
28. Tucker JD, Li JZ, Robbins GK, et al. Ocular syphilis among HIV-infected patients: a systematic analysis of the literature. Sex Trans Infect. 2011;87:4-8.
29. Rottingen JA, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much is really known? Sex Transm Dis. 2001;28:579-597.
30. French P. Syphilis. BMJ. 2007;334:143-147.
31. Syphilis. In: Kimberlin DW, Brady MT, eds. Red Book: 2015 report of the Committee on Infectious Diseases. 30th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2015:755-768.
32. Singh AE, Romanowski B. Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features. Clin Microbiol Rev. 1999;12:187-209.
33. Fojaco RM, Hensley GT, Moskowitz L. Congenital syphilis and necrotizing funisitis. JAMA. 1989;261:1788-1790.
34. Hammerschlag MR, Guillén CD. Medical and legal implications of testing for sexually transmitted infections in children. Clin Microbiol Rev. 2010;23:493-506.
35. Cummings MC, Lukehart SA, Marra C, et al. Comparison of methods for the detection of Treponema pallidum in lesions of early syphilis. Sex Transm Dis. 1996;23:366-369.
36. Radolf JD, Tramont EC, Salazar JC. Treponema pallidum (syphilis). In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 8th ed. Missouri: WB Saunders, Elsevier; 2014: chapter 239.
37. Wheeler HL, Agarwal S, Goh BT. Dark ground microscopy and treponemal serological tests in the diagnosis of early syphilis. Sex Transm Infect. 2004;80:411-414.
38. Romanowski B, Forsey E, Prasad E, et al. Detection of Treponema pallidum by a fluorescent monoclonal antibody test. Sex Transm Dis. 1987;14:156-159.
39. Anderson J, Mindel A, Tovey SJ, et al. Primary and secondary syphilis, 20 years' experience. 3: Diagnosis, treatment, and follow up. Genitourin Med. 1989;65:239-243.
40. Luger AF. Serological diagnosis of syphilis: current methods. In: Young H, McMillan A, eds. Immunological diagnosis of sexually transmitted diseases. New York, NY: Dekker; 1988:249-274.
41. Fischbach FT. Syphilis detection tests. In: A manual of laboratory & diagnostic tests. 6th ed. Philadelphia, PA: Lippincott; 2000:581-583.
42. Peeling RW, Ye H. Diagnostic tools for preventing and managing maternal and congenital syphilis: an overview. Bull World Health Organ. 2004;82:439-446.
43. Schmidt BL, Edjlalipour M, Luger A. Comparative evaluation of nine different enzyme-linked immunosorbent assays for determination of antibodies against Treponema pallidum in patients with primary syphilis. J Clin Microbiol. 2000;38:1279-1282.
44. Lefevre JC, Bertrand MA, Bauriaud R. Evaluation of the Captia enzyme immunoassays for detection of immunoglobulins G and M to Treponema pallidum in syphilis. J Clin Microbiol. 1990;28:1704-1707.
45. Alessi E, Scioccati L. TPHA test. Experience at the Clinic of Dermatology, University of Milan. Br J Vener Dis. 1978;54:151-154.
46. Deacon WE, Lucas JB, Price EV. Fluorescent treponemal antibody-absorption (FTA-ABS) test for syphilis. JAMA. 1966;198:624-628.
47. Spangler AS, Jackson JH, Fiumara NJ, et al. Syphilis with a negative blood test reaction. JAMA. 1964;189:87-90.
48. Smith G, Holman RP. The prozone phenomenon with syphilis and HIV-1 co-infection. South Med J. 2004;97:379-382.
49. Shahrook S, Mori R, Ochirbat T, et al. Strategies of testing for syphilis during pregnancy. Cochrane Database Syst Rev. 2014;(10):CD010385.
50. Pan American Health Organization (PAHO). Guidance on syphilis testing in Latin America and the Caribbean: improving uptake, interpretation, and quality of testing in different clinical settings. 2015. http://www.paho.org (last accessed 26 September 2016).
51. Centers for Disease Control and Prevention (CDC). Syphilis - CDC Fact Sheet (Detailed). http://www.cdc.gov/ (last accessed 26 September 2016).
52. Centers for Disease Control and Prevention (CDC). Discordant results from reverse sequence syphilis screening--five laboratories, United States, 2006-2010. MMWR Morb Mortal Wkly Rep. 2011;60:133-137.
53. Luger AF, Schmidt BL, Kaulich M. Significance of laboratory findings for the diagnosis of neurosyphilis. Int J STD AIDS. 2000;11:224-234.
54. van Voorst Vader PC. Syphilis management and treatment. Dermatol Clin. 1998;16:699-711.
55. Perdrup A, Jorgensen BB, Pedersen NS. The profile of neurosyphilis in Denmark. A clinical and serological study of all patients in Denmark with neurosyphilis disclosed in the years 1971-1979 incl. by Wassermann reaction (CWRM) in the cerebrospinal fluid. Acta Derma Venereol Suppl (Stockh). 1981;96:1-14.
56. Lavi R, Yarnitsky D, Rowe JM, et al. Standard vs atraumatic Whitacre needle for diagnostic lumbar puncture: a randomized trial. Neurology. 2006 Oct 24;67(8):1492-4.
57. Arendt K, Demaerschalk BM, Wingerchuk DM, Camann W. Atraumatic lumbar puncture needles: after all these years, are we still missing the point? Neurologist. 2009 Jan;15(1):17-20.
58. Nath S, Koziarz A, Badhiwala JH, et al. Atraumatic versus conventional lumbar puncture needles: a systematic review and meta-analysis. Lancet. 2018 Mar 24;391(10126):1197-1204.
59. Rochwerg B, Almenawer SA, Siemieniuk RAC, et al. Atraumatic (pencil-point) versus conventional needles for lumbar puncture: a clinical practice guideline. BMJ. 2018 May 22;361:k1920.
60. Ahmed SV, Jayawarna C, Jude E. Post lumbar puncture headache: diagnosis and management. Postgrad Med J. 2006 Nov;82(973):713-6.
61. Arevalo-Rodriguez I, Ciapponi A, Roqué i Figuls M, et al. Posture and fluids for preventing post-dural puncture headache. Cochrane Database Syst Rev. 2016 Mar 7;(3):CD009199.
62. US Preventive Services Task Force. Screening for syphilis infection in pregnancy: US Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2009;150:705-709.
63. Hollier LM, Harstad TW, Sanchez PJ, et al. Fetal syphilis: clinical and laboratory characteristics. Obstet Gynecol. 2001;97:947-953.
64. Cole M, Perry K. MHRA 04109: ten syphilis EIAs. UK: HSMO; 2004.
65. Creegan L, Bauer HM, Samuel MC, et al. An evaluation of the relative sensitivities of the venereal disease research laboratory test and the Treponema Pallidum particle agglutination test among patients diagnosed with primary syphilis. Sex Transm Dis. 2007;34:1016-1108.
66. Manavi K, Young H, McMillan A. The sensitivity of syphilis assays in detecting different stages of early syphilis. Int J STD AIDS. 2006;17:768-771.
67. Lam TK, Lau HY, Lee YP, et al. Comparative evaluation of the INNO-LIA syphilis score and the MarDx Treponema pallidum immunoglobulin G Marblot test assays for the serological diagnosis of syphilis. Int J STD AIDS. 2010;21:110-113.
68. Hagedorn HJ, Kraminer-Hagedorn A, de Bosschere K, et al. Evaluation of INNO-LIA syphilis assay as a confirmatory test for syphilis. J Clin Microbiol. 2002;40:973-978.
69. Van Dyck E, Meheus AZ, Piot P. Syphilis. In: Laboratory diagnosis of sexually transmitted diseases. Geneva: World Health Organization; 1999:36-49.
70. Palmer HM, Higgins SP, Herring AJ, et al. Use of PCR in the diagnosis of early syphilis in the United Kingdom. Sex Transm Dis. 2003;79:479-483.
71. Lewis DA. Chancroid: clinical manifestations, diagnosis, and management. Sex Transm Infect. 2003;79:68-71.
72. Patterson K, Olsen B, Thomas C, et al. Development of a rapid immunodiagnostic test for Haemophilus ducreyi. J Clin Microbiol. 2002;40:3694-3702.
73. Young H. Guidelines for serological testing for syphilis. Sex Transm Infect. 2000;76:403-405.
74. United States Preventive Services Task Force. Syphilis infection in nonpregnant adults and adolescents: screening. July 2016. http://www.uspreventiveservicestaskforce.org/ (last accessed 26 September 2016).
75. Pope V. Use of treponemal tests to screen for syphilis. Infect Med. 2004;21:399-402.
76. Tucker JD, Bu J, Brown LB, et al. Accelerating worldwide syphilis screening through rapid testing: a systematic review. Lancet Infect Dis. 2010;10:381-386.
77. British Association for Sexual Health and HIV (BASHH) Clinical Effectiveness Group. 2015 BASHH CEG guidance on tests for sexually transmitted infections. April 2015. http://www.bashh.org/ (last accessed 26 September 2016).
78. Centers for Disease Control and Prevention. Recommendations for partner services programs for HIV infection, syphilis, gonorrhea, and chlamydial infection. MMWR Recomm Rep. 2008;57:1-83.
79. Menezes EV, Yakoob MY, Soomro T, et al. Reducing stillbirths: prevention and management of medical disorders and infections during pregnancy. BMC Pregnancy Childbirth. 2009;9(suppl 1):S4.
80. Hawkes SJ, Gomez GB, Broutet N. Early antenatal care: does it make a difference to outcomes of pregnancy associated with syphilis? A systematic review and meta-analysis. PLoS One. 2013;8:e56713.
81. Wolff T, Shelton E, Sessions C, at al. Screening for syphilis infection in pregnant women: evidence for the U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2009;150:710-716.
82. Blencowe H, Cousens S, Kamb M, et al. Lives Saved Tool supplement detection and treatment of syphilis in pregnancy to reduce syphilis related stillbirths and neonatal mortality. BMC Public Health. 2011;11(suppl 3):S9.
83. Chen XS, Peeling RW, Yin YP, Mabey D. Improving antenatal care to prevent adverse pregnancy outcomes caused by syphilis. Future Microbiol. 2011;6:1131-1134.
84. Hawkes S, Matin N, Broutet N, et al. Effectiveness of interventions to improve screening for syphilis in pregnancy: a systematic review and meta-analysis. Lancet Infect Dis. 2011;11:684-691.
85. Munkhuu B, Liabsuetrakul T, Chongsuvivatwong V, et al. One-stop service for antenatal syphilis screening and prevention of congenital syphilis in Ulaanbaatar, Mongolia: a cluster randomized trial. Sex Transm Dis. 2009;36:714-720.
86. US Preventive Services Task Force. Screening for syphilis infection in pregnancy: US Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2009;150:705-709.
87. Chow EP, Wilson DP, Zhang L. HIV and syphilis co-infection increasing among men who have sex with men in China: a systematic review and meta-analysis. PLoS One. 2011;6:e22768.
88. British Association for Sexual Health and HIV (BASHH). UK national guidelines on the management of syphilis. December 2015. http://www.bashh.org/ (last accessed 26 September 2016).
89. Stoner BP. Current controversies in the management of adult syphilis. Clin Infect Dis. 2007;44(suppl 3):S130-S146.
90. Parkes R, Renton A, Meheus A, et al. Review of current evidence and comparison for effective syphilis treatment in Europe. Int J STD AIDS. 2004;15:73-88.
91. Janier M, Hegyi V, Dupin N, et al. 2014 European guideline on the management of syphilis. J Eur Acad Dermatol Venereol. 2014:28:1581-1593.
92. Hook EW 3rd, Martin DH, Stephens J, et al. A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. Sex Transm Dis. 2002;29:486-490.
93. Riedner G, Rusizoka M, Todd J, et al. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med. 2005;353:1236-1244.
94. Lukehart SA, Godornes C, Molini BJ, et al. Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med. 2004;351:154-158.
95. Yim CW, Flynn NM, Fitzgerald FT. Penetration of oral doxycycline into the cerebrospinal fluid of patients with latent or neurosyphilis. Antimicrob Agents Chemother. 1985;28:347-348.
96. Saxon A, Beall GN, Rohr AS, et al. Immediate hypersensitivity reactions to beta-lactam antibiotics. Ann Intern Med. 1987;107:204-215.
97. Wendel GD Jr, Stark BJ, Jamison RB, et al. Penicillin allergy and desensitization in serious infections during pregnancy. N Engl J Med. 1985;312:1229-1232.
98. Blank LJ, Rompalo AM, Erbelding EJ, et al. Treatment of syphilis in HIV-infected subjects: a systematic review of the literature. Sex Transm Infect. 2011;87:9-16.
99. Hook EW 3rd, Behets F, Van Damme K, et al. A phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilis. J Infect Dis. 2010;201:1729-1735.
100. Bai ZG, Yang KH, Liu YL, et al. Azithromycin vs. benzathine penicillin G for early syphilis: a meta-analysis of randomized clinical trials. Int J STD AIDS. 2008;19:217-221.
101. Katz KA, Klausner JD. Azithromycin resistance in Treponema pallidum. Curr Opin Infect Dis. 2008;21:83-91.
102. Marra CM, Boutin P, McArthur JC, et al. A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals. Clin Infect Dis. 2000;30:540-544.
103. Romanowski B, Sutherland R, Fick GH, et al. Serologic response to treatment of infectious syphilis. Ann Intern Med. 1991;114:1005-1009.
104. Gudjonsson H, Skog E. The effect of prednisolone on the Jarisch-Herxheimer reaction. Acta Derm Venereol. 1968;48:15-18.
105. Fekade D, Knox K, Hussein K, et al. Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha. N Engl J Med. 1996;335:311-315.
106. Kryst L, Wanyura H. Hoigne's syndrome - its course and symptomatology. J Maxillofac Surg. 1979;7:320-326.
107. Ng BE, Butler LM, Horvath T, et al. Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection. Cochrane Database Syst Rev. 2011;(3):CD001220.
108. de Walque D, Dow WH, Nathan R, et al. Incentivising safe sex: a randomised trial of conditional cash transfers for HIV and sexually transmitted infection prevention in rural Tanzania. BMJ Open. 2012;2:e000747.
109. British Association for Sexual Health and HIV (BASHH). United Kingdom national guideline on the management of sexually transmitted infections and related conditions in children and young people - 2010. http://www.bashh.org (last accessed 26 September 2016).
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台